v3.25.3

Condensed Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 25,508	$ 40,235
Short-term investments	97,460	145,193
Other receivables (including related party amounts of $37 and $0, respectively)	79	146
Prepaid expenses and other current assets	6,477	3,057
Total current assets	129,524	188,631
Restricted cash	461	258
Property and equipment, net	6,981	6,370
Operating lease right-of-use assets	11,262	13,794
Financing lease right-of-use asset	216	261
Other long-term assets	418	267
Total assets	148,862	209,581
Current liabilities:
Accounts payable (including related party amounts of $0 and $276, respectively)	848	1,121
Accrued expenses (including related party amounts of $12 and $713, respectively)	7,026	7,392
Current portion of operating lease liabilities	3,097	3,618
Current portion of financing lease liability	75	122
Other current liabilities	73
Total current liabilities	11,119	12,253
Operating lease liabilities, net of current portion	8,519	10,570
Financing lease liability, net of current portion		44
Other non-current liabilities		73
Total liabilities	19,638	22,940
Commitments and contingencies (Note 10)
Stockholders' equity :
Preferred stock, $0.0001 par value; 10,000,000 shares authorized at September 30, 2025 and December 31, 2024; zero shares issued and outstanding as of September 30, 2025 and December 31, 2024
Common stock, $0.0001 par value; 700,000,000 shares authorized at September 30, 2025 and December 31, 2024; 24,544,904 and 24,291,607 shares issued and outstanding at September 30, 2025 and December 31, 2024 respectively	3	3
Additional paid-in capital	438,911	433,451
Accumulated other comprehensive income (loss)	87	(129)
Accumulated deficit	(309,777)	(246,684)
Total stockholders' equity	129,224	186,641
Total liabilities and stockholders' equity	$ 148,862	$ 209,581

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Artiva Biotherapeutics, Inc. 10-Q